MINNEAPOLIS - Almost two-thirds of the people admitted to an Italian hospital with COVID-19 in March experienced losing their senses of smell and taste, according to a study published in the December 9, 2020, online issue of Neurology® Clinical Practice, an official journal of the American Academy of Neurology. Additionally, about 22% of those with impaired sense of smell and taste said it was their first symptom of infection.
"Loss of smell and taste are common in people who have COVID-19 infections, and our study found that these symptoms often occur before other symptoms, like fever or shortness of breath," said study author Francesco Bax, M.D., of Santa Maria della Misericordia University Hospital in Udine, Italy. "Because of that, clinicians should consider a patient's loss of smell and taste an early indication of infection, one that is monitored closely while keeping that patient isolated, and possibly quarantined, until a definitive diagnosis can be made. While many people show evidence of COVID-19 infection in the lungs, we found there could be more at play than what a person's lungs can tell us."
The study involved 93 people with an average age of 63 who were admitted to the non-intensive COVID-19 unit of the hospital in March 2020. The participants either tested positive for the virus with a swab test, or they showed signs of lung problems with a chest X-ray or scan. They were also interviewed about their symptoms.
Loss of smell and taste were present in 58 people, or 63% of the group. For 13 of the 58, or 22%, the loss of smell and taste was their first symptom. Average duration of the loss of smell and taste was 25 to 30 days.
Researchers also looked at blood work to see if there were certain biomarkers of inflammation. Compared to coronavirus-infected patients who didn't lose their sense of smell and taste, the people with compromised sense of smell had lower amounts of white blood cells, or leukocytes. In particular, a specific subset of white blood cells called neutrophils was reduced. These cells also help the body fight infection.
The people who lost their sense of smell had an average of 4,695 leukocytes per microliter (μL), compared to 6,010/μL in those with a normal sense of smell, a decrease of 23%. The people who lost their sense of smell had an average of 3,250 neutrophils/μL, compared to an average of 3,960/μL in those with a normal sense of smell, a decrease of 29%.
"More research is needed to determine whether this decrease in white blood cells we observed can be used to help identify patients in the early stages of COVID-19 infection," said Bax. "For people whose first symptoms were loss of taste and smell, we found very few had nasal congestion, so we think obstruction of the nasal passages is an unlikely cause of these symptoms. However, the association between a blood cell imbalance and losing your sense of smell may help in identifying patients at risk."
A limitation of the study is that only the patients remaining in the hospital were interviewed in person, while people already discharged from the hospital were interviewed over the phone.
###
Learn more about COVID-19 at BrainandLife.org, home of the American Academy of Neurology's free patient and caregiver magazine focused on the intersection of neurologic disease and brain health. Follow Brain & Life® on Facebook, Twitter and Instagram.
When posting to social media channels about this research, we encourage you to use the hashtags #Neurology and #AANscience.
The American Academy of Neurology is the world's largest association of neurologists and neuroscience professionals, with over 36,000 members. The AAN is dedicated to promoting the highest quality patient-centered neurologic care. A neurologist is a doctor with specialized training in diagnosing, treating and managing disorders of the brain and nervous system such as Alzheimer's disease, stroke, migraine, multiple sclerosis, concussion, Parkinson's disease and epilepsy.
For more information about the American Academy of Neurology, visit AAN.com or find us on Facebook, Twitter, Instagram, LinkedIn and YouTube.
Additional Media Contact:
Renee Tessman,
rtessman@aan.com,
(612) 928-6137
Journal
Neurology